Find More Contacts for Juno Therapeutics
Protected Content
Principal
Non-Management, Director Operations
3 emails found
View contacts for Juno Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Number of Exits 
  • Contact Email Info@junotherapeutics.com
  • Phone Number +1 206-696-0703

Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. With one of the largest ever Series A

investments for a biotech startup, Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs.

Lists Featuring This Company

Seattle Companies With More Than 50 Employees
1,595 Number of Organizations • $39.2B Total Funding Amount • 2,020 Number of Investors
West Coast Biotechnology Female Founded Acquired Companies
75 Number of Organizations • $5.8B Total Funding Amount • 372 Number of Investors
Acquired United States Companies (Top 10K)
9,745 Number of Organizations • $935.8B Total Funding Amount • 49,100 Number of Investors
United States Biotechnology Female Founded Companies
1,745 Number of Organizations • $126.5B Total Funding Amount • 6,891 Number of Investors
Juno Therapeutics was acquired by Celgene for $9B on Jan 22, 2018.

Frequently Asked Questions

Where is Juno Therapeutics's headquarters? Juno Therapeutics is located in Seattle, Washington, United States.Who invested in Juno Therapeutics? Juno Therapeutics has 4 investors including ARCH Venture Partners and Bezos Expeditions.How much funding has Juno Therapeutics raised to date? Juno Therapeutics has raised .When was the last funding round for Juno Therapeutics? Juno Therapeutics closed its last funding round on Aug 5, 2014 from a Series B round.Who are Juno Therapeutics's competitors? Alternatives and possible competitors to Juno Therapeutics may include Gritstone bioCarisma Therapeutics, and Tmunity Therapeutics.